Mammalian Transient Protein Expression Market Players:
-
Thermo Fisher Scientific Company
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merck KGaA
- Promega Corporation
- Lonza Group
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
- QIAGEN GmbH
- Takara Bio India Pvt. Ltd.
- HiMedia Laboratories Pvt Ltd
- Sino Biological, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of mammalian transient protein expression is assessed at USD 493.36 million.
The global mammalian transient protein expression market size was valued at over USD 460.61 million in 2025 and is expected to expand at a CAGR of around 7.9%, surpassing USD 985.25 million revenue by 2035.
North America is projected to command the largest revenue share by 2035 in the mammalian transient protein expression market, supported by strengthening healthcare infrastructure, expanding government funding, and rising healthcare expenditures.
Key players in the market include Merck KGaA, Promega Corporation, Lonza Group, Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH, Takara Bio India Pvt. Ltd., HiMedia Laboratories Pvt Ltd, Sino Biological, Inc.
